163.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Insmed Inc Borsa (INSM) Ultime notizie
Is a relief rally coming for Insmed Incorporated holdersJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com
What dividend safety score for Insmed Incorporated stockPortfolio Value Summary & High Conviction Investment Ideas - newser.com
Does Insmed Incorporated (INSM) Have a Promising Pipeline? - Yahoo Finance
Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025 - MarketScreener
Q3 2025 Results on Oct. 30 — Insmed Schedules Investor Call; Live Webcast & Replay - Stock Titan
What moving averages say about Insmed IncorporatedMarket Volume Report & Long-Term Investment Growth Plans - newser.com
Biotech Fund Beating 92% of Peers Sees More M&A Deals to Come - Bloomberg.com
UBS Maintains Insmed (INSM) Buy Recommendation - Nasdaq
Can Insmed Incorporated hit a new high this monthMarket Performance Summary & Daily Entry Point Alerts - newser.com
UBS Raises Price Target for Insmed (INSM) Following Consistent " - GuruFocus
Insmed stock price target raised to $194 from $140 at UBS on new indications - Investing.com Canada
How Insmed Incorporated stock reacts to Fed rate cutsJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
UBS Adjusts Insmed Price Target to $194 From $140, Maintains Buy Rating - MarketScreener
Key metrics from Insmed Incorporated’s quarterly dataJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com
Insmed Incorporated stock prediction for this weekPortfolio Risk Summary & Growth Focused Entry Point Reports - newser.com
Can Insmed Incorporated stock maintain operating marginsJuly 2025 Reactions & High Accuracy Trade Signal Alerts - newser.com
What institutional flow reveals about Insmed IncorporatedJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
Is Insmed Incorporated trending in predictive chart modelsPortfolio Performance Report & High Return Trade Opportunity Guides - newser.com
What indicators show strength in Insmed IncorporatedPortfolio Gains Summary & Real-Time Market Trend Scan - newser.com
How to build a custom watchlist for Insmed IncorporatedPortfolio Risk Summary & Short-Term Swing Trade Alerts - newser.com
Real time alert setup for Insmed Incorporated performance2025 Key Lessons & Weekly Top Gainers Alerts - newser.com
Reversal indicators forming on Insmed Incorporated stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
How Insmed Incorporated (IM8N) stock performs during market turbulenceQuarterly Earnings Report & Safe Capital Growth Stock Tips - newser.com
Why Biotech’s Rally Can Last This Time - The Wall Street Journal
Insmed Incorporated (INSM) Stock Analysis: Biotechnology Growth with a 3.28% Potential Upside - DirectorsTalk Interviews
Maryland State Retirement & Pension System Invests $873,000 in Insmed, Inc. $INSM - MarketBeat
Aberdeen Group plc Decreases Stock Position in Insmed, Inc. $INSM - MarketBeat
Oak Ridge Investments LLC Sells 7,757 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed Insiders Sold US$36m Of Shares Suggesting Hesitancy - Yahoo Finance
Insmed, Inc. $INSM Holdings Raised by KLP Kapitalforvaltning AS - MarketBeat
How buyback programs support Insmed Incorporated (IM8N) stockMarket Activity Recap & Stepwise Entry and Exit Trade Signals - newser.com
Real time breakdown of Insmed Incorporated stock performanceJuly 2025 Market Mood & High Yield Stock Recommendations - newser.com
What does recent volatility data suggest for Insmed Incorporated2025 Price Targets & Reliable Breakout Stock Forecasts - newser.com
Insmed, Inc. Hits New 52-Week High of $163.22, Up 170% Yearly - Markets Mojo
Insmed stock hits 52-week high at 164.04 USD - Investing.com India
Insmed stock hits 52-week high at 164.04 USD By Investing.com - Investing.com Australia
How to interpret RSI for Insmed Incorporated stock2025 Support & Resistance & Reliable Breakout Forecasts - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Insmed (NASDAQ:INSM) - MarketBeat
Insmed, Inc. (NASDAQ:INSM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Insmed, Inc. Hits New 52-Week High of $160.62, Up 164% Yearly - Markets Mojo
Insmed, Inc. Hits New 52-Week High of $162.44, Up 171% Year-Over-Year - Markets Mojo
Pulmonary Arterial Hypertension Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Merck, Janssen Pharma, Aerovate Therapeutics, Novartis, Insmed Inc, Chugai Pharma - The Globe and Mail
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):